The long-term pharmacological action of cinnarizine nanoparticles based on biodegradable poly(D,L-lactide-co-glycolide) (PLGA) was studied using adult male Wistar rats (240 – 260 g). The reference drug was cinnarizine substance at a dose of 5.6 mg/kg. Changes in the cerebral hemodynamics were studied by ultrasound dopplerography, measured as the level of cerebral blood flow recorded over time intervals of 2, 4, 6, 8, 10, and 12 h and characterized by indicators of systolic linear and volumetric velocities of cerebral hemodynamics in terms of the Pourcelot and Gosling indices. The study revealed prolongation of the cinnarizine effect for 12 h, which favorably distinguished the developed PLGA dosage form from other drugs available on the pharmaceutical market, which is likely to mitigate side effects of the parent drug.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11094-021-02481-2/MediaObjects/11094_2021_2481_Fig1_HTML.jpg)
Similar content being viewed by others
References
P. B. Gorelick, A. Scuteri, S. E. Black, et al., Stroke, 42(9), 2672 – 2713 (2011).
O. S. Efimova, A. V. Slobodenyuk, A. A. Belkin, et al., Gig. Epidemiol., 48(8), 43 – 46 (2008).
N. V. Mazina, Candidate Dissertation in Medical Sciences, Volgograd (2016).
M. R. Ashrafi, S. Salehi, R. A. Malamiri, et al., Pediatr. Neurol., 51(4), 503 – 508 (2014); https://doi.org/10.1016/j.pediatrneurol.2014.05.031.
S. Shi, H. Chen, Y. Cui, et al., Int. J. Pharm., 373, 147 – 155 (2009); https://doi.org/10.1016/j.ijpharm.2009.02.006.
M. V. Sorokoumova, V. A. Kompantsev, L. I. Shcherbakova, et al., Vestn. VGU, Ser.: Khim., Biol. Farm., No. 4, 135 – 140 (2017).
S. Raghuvanshi and K. Pathak, J. Drug. Deliv., 2014, 479246 (2014); https://doi.org/10.1155/2014/479246.
M. V. Sorokoumova, L. I. Shcherbakova, et al., RU Pat. 2,727,964 C1, Jul. 28, 2020; findpatent.ru, No. 22, 11 (2020).
A. Vasconcelos, E. Vega, Y. Perez, et al., Int. J. Nanomed., No. 10, 609 – 631 (2015).
P. Gentile, V. Chiono, I. Carmagnola, et al., Int. J. Mol. Sci., 15(3), 3640 – 3659 (2014).
A. V. Voronkov, N. B. Shabanova, M. P. Voronkova, et al., Farm. Farmakol., 6(6), 548 – 567 (2018).
L. E. Nazarova and I. N. D’yakova, Med. Vestn. Bashk., 6(3), 133 – 135 (2011).
B. Li, G.-Q. Yang, S.-H. Fang, et al., Eur. J. Pharm. Sci., 40(3), 197 – 201 (2010).
A. A. Shahba, K. Mohsin, and F. K. Alanazi, AAPS PharmSciTech, 13(3), 967 – 977 (2012).
A. V. Voronkov, D. I. Pozdnyakov, K. A. Miroshnichenko, et al., Eksp. Klin. Farmakol., 82(11), 11 – 14 (2019).
S. Glantz, Primer of Biostatistics, 4th Ed., McGraw-Hill Inc., New York (1997), 473 pp.
Z. Babar, T. M. Gammie, D. Gnjidic, E. Reeve, et al., Cochrane Database Syst. Rev., 2017(2), CD012572 (2017); https://doi.org/10.1002/14651858.CD012572
J. Guo, X. Xiong, Y. Cao, et al., Evidence-Based Complementary Altern. Med., No. 2019, 8484263 (2019); https://doi.org/10.1155/2019/8484263.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 55, No. 8, pp. 38 – 42, August, 2021.
Rights and permissions
About this article
Cite this article
Sorokoumova, M.V., Pozdnyakov, D.I., Kompantsev, D.V. et al. Evaluation of the Long-Term Action of Cinnarizine Nanoparticles Based on Poly(D,L-Lactide-Co-Glycolide). Pharm Chem J 55, 706–710 (2021). https://doi.org/10.1007/s11094-021-02481-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-021-02481-2